Headache
Q&A: What is ‘keto flu’?
People who start a ketogenic diet may experience influenza-like symptoms in the first few weeks, according to a study published in Frontiers in Nutrition.
FDA approves Vyepti, first IV preventive treatment for migraine
The FDA has recently approved Vyepti, the first IV calcitonin gene-related peptide blocker for migraine prevention in adults, according to a press release from the manufacturer.
People with cluster headache take twice as many sick days
People with cluster headache take twice the number of sick days as those without the disorder, according to a study published in Neurology, the medical journal of the American Academy of Neurology.
Visual disturbance with undiagnosed etiology
A 20-year-old woman presented for a neuro-optometric exam with complaints of headaches, asthenopia, occasional diplopia, extreme light sensitivity, dizziness and loss of balance. She reported her symptoms started about 2 years ago with day-to-day fluctuations in her symptoms.
Ace the Case: A 63-Year-Old Man With a 1-Week History of Headache and Neck Pain
DHE re-emerges as ‘magic’ migraine treatment
Acute migraine treatments containing dihydroergotamine, or DHE, could soon return to the mainstream, providing a less cumbersome treatment option for some of the 39 million Americans with migraine, several neurologists told Healio Primary Care.
Pediatric migraine prevention guideline focuses on lifestyle choices
Pharmacologic treatments to prevent migraine in children and teens are effective, but so is placebo, complicating the issue for clinicians and families. Guidance from the American Academy of Neurology and the American Headache Society suggests that clinicians should counsel their patients on lifestyle and behavioral factors that contribute to migraine frequency, and it encourages shared decision-making with patients and caregivers regarding the use of preventive medication.
Neurolens enhances eye measurement software
EyePromise launches nutraceutical for digital eye strain
The eye health nutraceutical company, EyePromise, recently introduced Screen Shield Pro as the newest addition in its eye vitamin line.
Eptinezumab provides ‘rapid, robust’ benefit in patients with migraine
PHILADELPHIA — Patients who received eptinezumab, a monoclonal antibody that inhibits calcitonin gene-related peptide, had more migraine-free months than those who received placebo, according to study results presented at the American Headache Society Annual Scientific Meeting.